The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Daratumumab (DARA) + lenalidomide, bortezomib, and dexamethasone (RVd) in transplant-eligible newly diagnosed multiple myeloma (NDMM): A post hoc analysis of sustained minimal residual disease (MRD) negativity from GRIFFIN.
 
Cesar Rodriguez
Consulting or Advisory Role - AbbVie; Artiva; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Takeda
Speakers' Bureau - AbbVie; Artiva; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Takeda
 
Jonathan L. Kaufman
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Incyte; TG Therapeutics
Research Funding - Abbvie/Genentech (Inst); Amgen (Inst); BMS (Inst); Celgene (Inst); Fortis (Inst); Janssen (Inst); Merck (Inst); Sutro Biopharma (Inst)
 
Jacob Laubach
No Relationships to Disclose
 
Douglas W. Sborov
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Legend Biotech; Sanofi; Skyline Diagnostics
 
Brandi Reeves
Honoraria - Bristol-Myers Squibb; Incyte; PharmaEssentia
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda
Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda
 
Rebecca Wang Silbermann
Consulting or Advisory Role - Janssen Oncology; Oncopeptides; Sanofi/Aventis
Research Funding - Sanofi
 
Luciano J. Costa
Honoraria - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Karyopharm Therapeutics
Speakers' Bureau - Amgen; Sanofi
Research Funding - Amgen; Janssen
 
Larry D. Anderson
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; janssen; Karyopharm Therapeutics; Oncopeptides; Prothena
Consulting or Advisory Role - Abbvie; amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; janssen; Karyopharm Therapeutics; Oncopeptides; Prothena
Research Funding - amgen; bms; celgene; GlaxoSmithKline; janssen; Karyopharm Therapeutics
 
Nitya Nathwani
No Relationships to Disclose
 
Nina Shah
Consulting or Advisory Role - Amgen; CareDX; CSL Behring; Genentech/Abbvie; GlaxoSmithKline; Indapta Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Oncopeptides; Sanofi
Research Funding - Bluebird Bio; Celgene; Cellectis; Janssen; Nektar; poseida therapeutics; Precision Biosciences; Sutro biopharma; Teneobio
 
Naresh Bumma
Honoraria - OncLive
Consulting or Advisory Role - Genzyme; Janssen; Oncopeptides
Speakers' Bureau - Genzyme; Janssen; Oncopeptides
 
Andrzej J. Jakubowiak
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi
 
Robert Z. Orlowski
Stock and Other Ownership Interests - Asymmetric Therapeutics
Honoraria - AbbVie; BioTheryX; Bristol-Myers Squibb; GlaxoSmithKline; Karyopharm Therapeutics; Meridian Therapeutics; Monte Rosa Therapeutics; Neoleukin Therapeutics; Oncopeptides; Regeneron; Sanofi; Takeda
Consulting or Advisory Role - AbbVie; BioTheryX; Bristol-Myers Squibb; GlaxoSmithKline; Karyopharm Therapeutics; Meridian Therapeutics; Monte Rosa Therapeutics; Neoleukin Therapeutics; Oncopeptides; Regeneron; Sanofi; Takeda
Research Funding - Asymmetric Therapeutics; BioTheryX; Heidelberg Pharma
Patents, Royalties, Other Intellectual Property - Asymmetric Therapeutics
 
Huiling Pei
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Annelore Cortoos
Employment - Janssen
 
Sharmila Patel
Employment - Janssen
 
Thomas S. Lin
Employment - Janssen
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Secura Bio; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Peter M. Voorhees
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Oncopeptides; Pfizer; Sanofi; Secura Bio
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Sanofi
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline